Vinva Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Buy
428,099
+22,628
+6% +$602K 0.15% 158
2025
Q4
$10.1M Sell
405,471
-72,703
-15% -$1.83M 0.13% 159
2025
Q3
$11.4M Buy
478,174
+87,685
+22% +$2.16M 0.22% 116
2025
Q2
$9.45M Buy
390,489
+122,959
+46% +$2.87M 0.25% 107
2025
Q1
$6.74M Sell
267,530
-9,493
-3% -$248K 0.27% 96
2024
Q4
$7.32M Buy
277,023
+83,558
+43% +$2.27M 0.28% 79
2024
Q3
$5.63M Buy
193,465
+146,564
+312% +$4.28M 0.24% 107
2024
Q2
$1.3M Buy
46,901
+7,122
+18% +$196K 0.07% 260
2024
Q1
$1.1M Sell
39,779
-61,684
-61% -$1.71M 0.06% 280
2023
Q4
$2.92M Sell
101,463
-18,965
-16% -$573K 0.2% 127
2023
Q3
$3.86M Sell
120,428
-24,218
-17% -$856K 0.36% 67
2023
Q2
$5.22M Sell
144,646
-14,260
-9% -$555K 0.45% 49
2023
Q1
$6.42M Buy
+158,906
New +$6.86M 0.54% 45

Other funds holding PFE

Vinva Investment Management's PFE Position: Q1 2026 in Review

Vinva Investment Management increased its Pfizer (PFE) stake by 5.6% in Q1 2026, buying an estimated $602K and bringing the position to 428,099 shares worth $11.9M. The position accounts for 0.15% of the portfolio, ranked #158.

Vinva Investment Management first reported a position in PFE in Q1 2023 and has held it in 13 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Vinva Investment Management held 428,099 shares of Pfizer worth $11.9M as of Q1 2026.
  • Vinva Investment Management bought 22,628 Pfizer shares in Q1 2026, an estimated $602K.
  • Pfizer made up 0.15% of Vinva Investment Management's portfolio in Q1 2026, its #158 holding.
  • Vinva Investment Management first reported a position in Pfizer in Q1 2023 and has held it in 13 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.